OMICS: A NEW VISION FOR BREAST CANCER TREATMENT

Abstract

Breast cancer is an extremely heterogeneous disease with diverse morphologies, molecular characteristics, and clinical behaviour whose causes include interactions of both genetic and environmental factors. Currently, more than 2,261,419 cases and 684,996 deaths are reported each year worldwide and although great strides have been made, available treatments are inadequate for its most intractable forms. Therefore, knowing the associated molecular bases is essential to improve the prognosis and survival. The omics are high performance technologies utilized to quantify cellular components at a large scale. In this regard, this article presents genomic, epigenomic, transcriptomic, and proteomic research on breast cancer, in an attempt to understand and identify potential therapeutic molecular targets.